




I entered the science field because I imagined that scientists were
society’s “professional risk takers”, that they like surfing out on the
edge. I understood that a lot of science – perhaps evenmost science –
has to be a solid exploration of partly understood phenomena. But any
science that confronts a difficult problem has to start with risk. Most
people are at least a bit suspicious of risk, and scientists such as
myself are no exception. Recently, risk-taking has been under attack
financially, but this Editorial is not about that. I amwriting about the long
viewand themessages we send to our trainees. I amSenior Associate
Dean of the graduate school at Mount Sinai and have had the privilege
to discuss these issueswith the next generation of scientists, for whom
I care very deeply. Are we preparing you to embrace risk?
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Culture of risk
As a long-standing academic scientist, I like my tenure and my
funding to arrive with minimum risk. Although this is a reasonable
response towanting a good life, it is not always the optimal approach
for solving 21st-century biomedical problems. It discourages risk-
taking and encourages playing to the grant agencies. Worst of all,
my generation’s fear of risk bleeds down to you. We teach you
how to design projects that are ‘bullet-proof’. You will build the
Biomedicine Age, and you will need to take risks to do it.
“…a lot of science – perhaps even most
science – has to be a solid exploration of
partly understood phenomena. But any
science that confronts a difficult problem
has to start with risk”
A friend and serial entrepreneur once commented that
“scientists can be quick to ‘go negative’…unusual ideas are met
with ‘that won’t work’”. I would not go that far, but he does have a
point. Most risky ideas don’t pan out and, if I just dismiss them,
my batting average will be pretty high. But hard problems will
never get solved, and some of the magic of science is lost. Try a
lab meeting some time with a simple rule: no negative comments,
only “yes, and…”. Perhaps the student’s idea is not exactly right
but the really great idea is lurking nearby. Kill the first, and the
great idea is also lost. This all feeds to a culture of innovation and
risk.
“Most risky ideas don’t pan out and, if I
just dismiss them, my batting average will
be pretty high. But hard problems will
never get solved, and some of the magic
of science is lost”
Risk in the Biomedicine Age
Biomedical science today is in a similar position as the computer
industry of the early 1980s. Then, computer research was dominated
by government funding and made up mainly by academics, mostly
physicists and mathematicians. The government decided that it was
not going to increase funding and the computer industry was faced
with a challenge. The next generation was all in: they believed they
could make a difference, and they did. They opened their garages and
built the Information Age. If you tell someone in Silicon Valley that a
great project is risky, that’s considered a bonus.
We are now entering the Biomedicine Age. Our great challenge is
to understand how our body works and bring that understanding to
erasing disease. Cancer, heart disease, infection, neurodegenerative
diseases and – perhaps our most profound health challenge –mental
illness all represent hard problems that will transform who we are
when they are solved. The key words here are ‘risk’ and ‘diversity’
(more on diversity in a future Editorial). Biomedical challenges will
require biology PhD’s entering basic research as explorers,
industrial research to create therapeutics, Wall Street to build its
financial underpinnings, and professional communicators to explain
it all to society. The brains-in-the-garage are…you.
This will require loving risk. Start a company. It will probably fail
(mine did), but then start another (working on that). Worried that
funding for startups is tight, that you will confront the ‘valley of
death’? There is a much better financial structure now in biomedicine
than there was for computers 30 years ago. We need your creativity.
Apps, small devices, computational algorithms, blogs, newmaterials,
innovative teaching etc. are all part of the Biomedicine Age. Create a
new way of thinking about old problems and find a way to make your
solution happen. Then find someonewhowill mentor you, encourage
you that your idea is actually great. Succeeding will be sweet.
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